Literature DB >> 32782102

The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.

Nikhil Seval1, Alysse Wurcel2, Craig G Gunderson3, Alyssa Grimshaw4, Sandra A Springer5.   

Abstract

Hepatitis C virus (HCV) is highly prevalent in the criminal justice system and in persons who inject drugs, particularly opioids. Data on the impact of medications for opioid use disorder (MOUD) are abundant for infectious and noninfectious outcomes but are limited for justice-involved settings. This systematic review and meta-analysis focuses on the impact of MOUD on HCV incidence for persons in prisons and jails. Six studies were included in the qualitative synthesis, of which four were included for meta-analysis. A varied MOUD effect on HCV incidence was observed in part due to wide variability in prison and jail risk environments.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis C virus; Incarceration; Incidence; Medications for opioid use disorder; Methadone

Mesh：

Substances：

Year:  2020        PMID： 32782102      PMCID： PMC7437982          DOI： 10.1016/j.idc.2020.06.011

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  31 in total

Review 1.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

2.  Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.

Authors:  Sandra A Springer; Angela Di Paola; Russell Barbour; Marwan M Azar; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

Review 3.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 5.  Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis.

Authors:  Sarah Larney; Hannah Kopinski; Curt G Beckwith; Nickolas D Zaller; Don Des Jarlais; Holly Hagan; Josiah D Rich; Brenda J van den Bergh; Louisa Degenhardt
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

6.  Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.

Authors:  Jon E Zibbell; Alice K Asher; Rajiv C Patel; Ben Kupronis; Kashif Iqbal; John W Ward; Deborah Holtzman
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

7.  A prospective study of hepatitis C incidence in Australian prisoners.

Authors:  Fabio Luciani; Neil Arvin Bretaña; Suzy Teutsch; Janaki Amin; Libby Topp; Gregory J Dore; Lisa Maher; Kate Dolan; Andrew R Lloyd
Journal:  Addiction       Date:  2014-07-15       Impact factor: 6.526

Review 8.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

9.  Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.

Authors:  Andrés Marco; Carlos Gallego; Joan A Caylà
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Authors:  Jack Stone; Hannah Fraser; Aaron G Lim; Josephine G Walker; Zoe Ward; Louis MacGregor; Adam Trickey; Sam Abbott; Steffanie A Strathdee; Daniela Abramovitz; Lisa Maher; Jenny Iversen; Julie Bruneau; Geng Zang; Richard S Garfein; Yung-Fen Yen; Tasnim Azim; Shruti H Mehta; Michael-John Milloy; Margaret E Hellard; Rachel Sacks-Davis; Paul M Dietze; Campbell Aitken; Malvina Aladashvili; Tengiz Tsertsvadze; Viktor Mravčík; Michel Alary; Elise Roy; Pavlo Smyrnov; Yana Sazonova; April M Young; Jennifer R Havens; Vivian D Hope; Monica Desai; Ellen Heinsbroek; Sharon J Hutchinson; Norah E Palmateer; Andrew McAuley; Lucy Platt; Natasha K Martin; Frederick L Altice; Matthew Hickman; Peter Vickerman
Journal:  Lancet Infect Dis       Date:  2018-10-29       Impact factor: 71.421
View more
  1 in total

1.  Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.

Authors:  Noor Taweh; Esther Schlossberg; Cynthia Frank; Ank Nijhawan; Irene Kuo; Kevin Knight; Sandra A Springer
Journal:  Int J Drug Policy       Date:  2021-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.